0001093557-22-000065.txt : 20220317 0001093557-22-000065.hdr.sgml : 20220317 20220317163027 ACCESSION NUMBER: 0001093557-22-000065 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220315 FILED AS OF DATE: 20220317 DATE AS OF CHANGE: 20220317 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dolan Matthew Vincent CENTRAL INDEX KEY: 0001914994 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51222 FILM NUMBER: 22748951 MAIL ADDRESS: STREET 1: 6340 SEQUENCE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DEXCOM INC CENTRAL INDEX KEY: 0001093557 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330857544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582000200 MAIL ADDRESS: STREET 1: 6340 SEQUENCE DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2022-03-15 0 0001093557 DEXCOM INC DXCM 0001914994 Dolan Matthew Vincent 6340 SEQUENCE DRIVE SAN DIEGO CA 92121 0 1 0 0 SVP Corporate Development Common Stock 2022-03-15 4 S 0 1016 412.41 D 7804 D Common Stock 2022-03-16 4 S 0 686 425.0 D 7118 D Common Stock 2022-03-17 4 S 0 484 450.0 D 6634 D On December 15, 2021, Mr. Dolan adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Dolan. The shares set forth above were sold pursuant to the 10b5-1 Plan. Included in this number are 6,634 unvested restricted stock units, 2,889 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,048 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 1,697 of which were granted on March 8, 2020 and shall vest through March 8, 2023. By: Jereme Sylvain For: Matthew V Dolan 2022-03-17